That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only ...

Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

Our Lady of Lourdes Regional Medical Center is embracing cutting-edge technology to transform how heart conditions are ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Medtronic (NYSE: MDT) today reported study results highlighting AFib detection with its Linq family of insertable cardiac monitors (ICM).

The study, recently published in the Journal of the American Heart Association, adds to a body of research dispelling the belief that people with irregular heart rhythms such as atrial fibrillation, ...

The study, recently published in the Journal of the American Heart Association, adds to a body of research dispelling the belief that people with irregular heart rhythms such as atrial fibrillation, ...